Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
-27.11%
Price
02.04.26
€49.40
Summary
This prediction is currently active. The prediction for Haemonetics Corp. disappoints with a performance of -27.11%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.106% | 5.106% |
| iShares Core DAX® | 3,07 % | 0,49 % |
| iShares Nasdaq 100 | 2,88 % | 0,08 % |
| iShares Nikkei 225® | 5,98 % | 3,03 % |
| iShares S&P 500 | 2,23 % | 0,05 % |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat